The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5-Independent Manner

    May 2025 in “ Experimental Dermatology
    Dorottya Ádám, József Arany, Kinga Tóth, on behalf of the Coll Cancer Richard Peto, T. Nyitrai, Balázs István Tóth, Szilárd Póliska, Christos C. Zouboulis, Attila Oláh
    Image of study
    TLDR Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.
    The study explores the effects of the TRPM5 antagonist triphenylphosphine oxide (TPPO) on human sebocytes, finding that TPPO enhances sebaceous lipogenesis and modulates immune responses independently of TRPM5. TPPO increases lipid production and alters cytokine expression, notably increasing IL-6 and decreasing IL-8, through pathways involving Akt, EGFR, and p38α MAPK. These changes suggest potential therapeutic benefits for inflammatory skin conditions like atopic dermatitis or psoriasis, without adverse effects on sebaceous glands. The study confirms that TRPM5 is not functionally active in sebocytes, and TPPO's effects are mediated through multiple signaling pathways, highlighting its potential in acne treatment strategies.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 7 results

    Similar Research

    5 / 90 results